Advertisement
UK markets closed
  • FTSE 100

    8,351.22
    +37.55 (+0.45%)
     
  • FTSE 250

    20,449.17
    +36.09 (+0.18%)
     
  • AIM

    779.30
    +2.88 (+0.37%)
     
  • GBP/EUR

    1.1624
    +0.0000 (+0.00%)
     
  • GBP/USD

    1.2496
    -0.0014 (-0.11%)
     
  • Bitcoin GBP

    49,788.35
    -1,183.76 (-2.32%)
     
  • CMC Crypto 200

    1,319.12
    +24.45 (+1.89%)
     
  • S&P 500

    5,184.90
    -2.80 (-0.05%)
     
  • DOW

    38,963.95
    +79.69 (+0.20%)
     
  • CRUDE OIL

    78.76
    +0.38 (+0.48%)
     
  • GOLD FUTURES

    2,324.50
    +0.30 (+0.01%)
     
  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     
  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     
  • DAX

    18,473.24
    +43.19 (+0.23%)
     
  • CAC 40

    8,135.99
    +60.31 (+0.75%)
     

Wall Street Remains Positive on Walgreens

Wall Street Remains Positive on Walgreens

Can Walgreens Exceed Analyst Expectations for Fiscal Q3 2018? The company is rated a 2.3 on a scale where one is a “strong buy” and five is a “strong sell.” It was rated a 2.0 at the end of June 2017. In comparison, CVS Health has a slightly better rating of 2.0, while Rite Aid (RAD) has a rating of 3.0.